Veeva Announces New Application to Optimize Quality Control Labs - Seite 2
Vault LIMS is part of the Vault Quality Suite, including Vault QMS, Vault QualityDocs, and Vault Training. Vault Quality Suite enables manufacturers to easily manage quality and lab operations in one unified solution and delivers the power and scalability needed across the life sciences value chain.
Vault LIMS is planned for availability in the second half of 2022. To learn more about Vault LIMS, visit veeva.com/eu/VaultLIMS or attend Veeva R&D and Quality Summit Connect on 14 October 2021.
Additional Information
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veeva_eu on Twitter: twitter.com/veeva_eu
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more
than 1,100 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all
stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.
Lesen Sie auch
Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of Veeva's products and services, the results from use of
Veeva's products and services, and general business conditions, particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva's
historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking
statements represent Veeva's expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the
forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional
risks and uncertainties that could affect Veeva's financial results are included under the captions, "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of
Operations," in the company's filing on Form 10-Q for the period ended July 31, 2021. This is available on the company's website at veeva.com under the Investors section and on
the SEC's website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.